Elevated PRL levels during MS and NMO attacks, particularly the more pronounced elevations observed during myelitis episodes, suggest a potential immunomodulatory role for PRL in the pathogenesis of autoimmune demyelinating diseases [113] (Table 3). Here, PRL is linked to myelitis.